On the first day of the 2nd International Al-Mustaqbal Conference: Dr. Aseel Fadel Karim presents advanced research on the design of multi-activity pharmaceutical compounds. Date: 25/04/2025 | Views: 604

Share in :

During the first day of the Second International Al-Mustaqbal Conference on Health Sciences and Technologies, Dr. Aseel Fadel Karim presented a qualitative scientific research paper entitled:

"The Design, Synthesis, and Research Activities of Some Heterocyclic Compounds, Such as Antiviral, Hypersensitive, and Antitumor Drugs"

The research addressed the design of new chemical compounds from the heterocyclic family and demonstrated their effective effects as promising pharmaceutical ingredients in the field of combating viruses, tumors, and allergies.

Dr. Aseel focused on the mechanisms of chemical synthesis of these compounds, in addition to studying their biological activity using advanced laboratory tests. This research provides a strong scientific platform for developing effective and sustainable future medicines.

The research received widespread attention from conference participants, given its intersection between medicinal chemistry and modern applied sciences, and its contribution to supporting pharmaceutical research to address future health challenges.

Al-Mustaqbal University is the leading university in Iraq.